Drug intelligence / Profile preview

tazarotene

Development stage
Approved
Lead developer
Allergan
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Tazarotene is a third-generation topical retinoid used primarily for the treatment of plaque psoriasis and acne vulgaris. It is also indicated for reducing facial wrinkling and discoloration associated with photoaged skin. Tazarotene is a prodrug that undergoes rapid conversion in the skin to its active metabolite, tazarotenic acid. The active form binds to all three members of the retinoic acid receptor (RAR) family—RARα, RARβ, and RARγ—with relative selectivity for RARβ and RARγ. This binding modulates gene expression involved in cell proliferation and differentiation. The drug exerts antiproliferative effects on keratinocytes, normalizes their differentiation, and downregulates markers of inflammation[2][4][5][6]. Tazarotene was originally developed by Allergan.

Brand names
TazoracAvageFabiorArazlo
Other names
tazarotenic acid
02

Targets

RARA (Retinoic acid receptor alpha)RARB (Retinoic acid receptor beta)RARG (Retinoic acid receptor gamma)RXRA (Retinoid X receptor alpha)

Beyond the preview

Go deeper on tazarotene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tazarotene.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call